Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center

PURPOSE: We compared risk factors for high disease- and treatment-related symptom burden over 15 weeks of therapy in medically underserved patients with advanced non–small-cell lung cancer and in patients treated at a tertiary cancer center. PATIENTS AND METHODS: We monitored symptom severity weekly...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Cleeland, Charles S., Mendoza, Tito R., Wang, Xin Shelley, Woodruff, Jeanie F., Palos, Guadalupe R., Richman, Stephen P., Nazario, Arlene, Lynch, Garrett R., Liao, Kai-Ping, Mobley, Gary M., Lu, Charles
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2011
Témata:
Original Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138716/
https://ncbi.nlm.nih.gov/pubmed/21690477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.4425
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky